# Rapid Micro Biosystems (RPID) Stock Price, News & Analysis
Canonical URL: https://biopharmsignal.com/company/RPID
## Company Profile
- Ticker: RPID
- Exchange: NASDAQ
- Sector: Biopharma
- Location: United States
## Stock Data
- Close: 2.08 USD
- Market cap: 97650745.64 USD
- Last updated: 2026-08-06
## Business Overview
### Automated Microbial Quality Control
Rapid Micro Biosystems provides automation systems used to test biologics, vaccines, cell and gene therapies, sterile injectables, and other healthcare products for microbial contamination.
### Growth Direct Platform
The Growth Direct system replaces manual microbial quality-control workflows with automated imaging, incubation, detection, and data handling inside regulated manufacturing facilities.
### Installed-Base Economics
Revenue combines instrument placements, validation services, recurring consumables, and ongoing service. As installed systems move into routine use, consumables and service create recurring revenue.
### Strategic Integration
The company is working with MilliporeSigma and large pharmaceutical customers to integrate Growth Direct into broader manufacturing and enterprise automation strategies.
## Why The Stock Is Moving

The latest monitored company update is “Rapid Micro Biosystems Reports Second Quarter 2026 Financial Results.” The corresponding closing-price reaction is not yet available.

## Future Catalysts

- Rapid Micro’s catalysts are Growth Direct adoption, recurring consumables, and any update that shows microbiology automation is becoming more embedded in labs. The story improves when platform usage becomes stickier.

## Recent News
- 2026-08-07 11:00 EST — [Rapid Micro Biosystems Reports Second Quarter 2026 Financial Results](https://biopharmsignal.com/news/RPID/rapid-micro-biosystems-reports-second-quarter-2026-financial-results-96221a52) — Source: Rapid Micro Biosystems
- 2026-08-04 20:30 EST — [Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/RPID/rapid-micro-biosystems-announces-inducement-grants-under-nasdaq-listing-rule-563-3e8d99d7) — Source: Rapid Micro Biosystems
- 2026-07-23 21:15 EST — [Rapid Micro Biosystems to Announce Second Quarter 2026 Financial Results on August 7, 2026](https://biopharmsignal.com/news/RPID/rapid-micro-biosystems-to-announce-second-quarter-2026-financial-results-on-augu-0f27c9ca) — Source: Rapid Micro Biosystems
- 2026-06-10 20:30 EST — [Rapid Micro Biosystems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/RPID/rapid-micro-biosystems-announces-inducement-grant-under-nasdaq-listing-rule-5635-326cd74a) — Source: Rapid Micro Biosystems
- 2026-05-19 01:55 EST — [Rapid Micro Biosystems Announces Pricing of Up to Approximately $32 Million Underwritten Offering](https://biopharmsignal.com/news/RPID/rapid-micro-biosystems-announces-pricing-of-up-to-approximately-32-million-underwritten-offering) — Source: Rapid Micro Biosystems